The Pharma Letter Podcast by

July 2021.

Israel-based Belong.Life is the creator of the world’s largest social network for cancer patients, and has ambitions to provide a range of networks across therapy areas.

The platform may be of interest for drug developers and other industry participants looking for opportunities to conduct market research or marketing efforts, or to boost clinical trial enrolment.

In this episode, The Pharma Letter discusses the potential for the platform with its chief executive, Eliran Malki, and medical director, Daniel Vorobiof.

Listen Now >

More Articles

More on Using AI to Enhance Cancer Care

Dave AI provides the cognitive assistant with organized and valuable information to be delivered in…

ASCO 2024: Oncologists support Belong.Life’s AI cancer mentor Dave

Belong.Life asked a group of senior oncologists to review the responses provided to patients and…

Lessons on AI Support for Cancer Care

The integration of artificial intelligence (AI) in oncology care has allowed for unprecedented levels of…
Skip to content